Mycobacterium Citations List: May 2023

Literature Citations

1. Imidazopyridine Amides: Synthesis, Mycobacterium Smegmatis CIII2 CIV2 Supercomplex Binding, and in Vitro Antimycobacterial Activity. Abdelaziz, R., J.M. Di Trani, H. Sahile, L. Mann, A. Richter, Z. Liu, S.A. Bueler, L.E. Cowen, J.L. Rubinstein, and P. Imming. ACS Omega, 2023. 8(21): p. 19081-19098. PMID[37273644]. PMCID[PMC10233671].
[PubMed]. TB_05_2023.

2. Wang-OSO3H Catalyzed One-pot Sonochemical Synthesis of 1,2,4-Benzothiadiazine-1,1-dioxide Derivatives: Their in Silico / in Vitro Assessments against MtbCM. Addu, N., H. Miriyala, R. Kapavarapu, S.K. Kolli, and M. Pal. Journal of Molecular Structure, 2023. 1283. ISI[000972627900001].
[WOS]. TB_05_2023.

3. Molecular Hybrid of 1,2,3-Triazole and Schiff Base as Potential Antibacterial Agents: DFT, Molecular Docking and ADME Studies. Belay, Y., A. Muller, P. Leballo, O.A. Kolawole, A.S. Adeyinka, T.Y. Fonkui, and L.R. Motadi. Journal of Molecular Structure, 2023. 1286: 135617. ISI[000988597700001].
[WOS]. TB_05_2023.

4. Synthesis and Identification of New Sacubitril Derivatives as Lead Compounds for Antibacterial, Antifungal and Antitubercular (TB) Activities against Dormant Tuberculosis. Bhargavi, D., S. Konduri, J. Prashanth, S. Pulipati, K.K. Praneeth, M. Sireesha, and K.P. Rao. RSC Advances, 2023. 13(20): p. 13540-13546. PMID[37152580]. PMCID[PMC10155492].
[PubMed]. TB_05_2023.

5. Synthesis, Antitubercular Evaluation, and Molecular Docking Studies of Hybrid Pyridinium Salts Derived from Isoniazid. Bhavani, G.V., S.K. Kondapuram, A.F. Shamsudeen, M.S. Coumar, J. Selvin, and T. Kannan. Drug Development Research, 2023. 84(3): p. 470-483. PMID[36744647].
[PubMed]. TB_05_2023.

6. Effective Synthesis and Anti-mycobacterial Activity of Isoxazole-substituted Piperazine Derivatives. Bi, Y.C., X.D. Chen, Y.F. Xue, K.J. Liu, Y.M. Zhang, and Q. Gu. ChemistrySelect, 2023. 8(18). ISI[000983930000001].
[WOS]. TB_05_2023.

7. Quinolone-3-amidoalkanol: A New Class of Potent and Broad-spectrum Antimicrobial Agent. Dube, P.S., K.T. Angula, L.J. Legoabe, A. Jordaan, J.M.B. Zarella, D.F. Warner, J.S. Doggett, and R.M. Beteck. ACS Omega, 2023. 8(19):17086-17102. PMID[37214682]. PMCID[PMC10193574].
[PubMed]. TB_05_2023.

8. Hesperidin Hexosomal Loaded Nanodispersion: Insights of Its Antimycobacterial, Cytotoxic and anti-HCoV Effects. Elghani, E.M.A., F.A. Omar, M.M.A. Emam, A.M. Al-Mahallawi, S.H. Tadros, F.M. Soliman, and A.M. ElSayed. Natural Product Research, 2023. 37(10): p. 1719-1724. PMID[35921497].
[PubMed]. TB_05_2023.

9. A Leucyl-tRNA synthetase Inhibitor with Broad-spectrum Anti-mycobacterial Activity. Ganapathy, U.S., R.G. Del Rio, M. Cacho-Izquierdo, F. Ortega, J. Lelièvre, D. Barros-Aguirre, M. Lindman, V. Dartois, M. Gengenbacher, and T. Dick. Antimicrobial Agents and Chemotherapy, 2023. 95(5). PMID[33558292]. PMCID[PMC8092876].
[PubMed]. TB_05_2023.

10. Rifaximin Potentiates Clarithromycin against Mycobacterium abscessus in Vitro and in Zebrafish. Goh, B.C., S. Larsson, L.C. Dam, Y.H.S. Ling, W.L.P. Chua, R. Abirami, S. Singh, J.L.E. Ong, J.W.P. Teo, P. Ho, P.W. Ingham, K. Pethe, and P.C. Dedon. JAC Antimicrobial Resistance, 2023. 5(3): dlad052. PMID[37168836]. PMCID[PMC10164658].
[PubMed]. TB_05_2023.

11. Polyfluorinated Salicylic acid Analogs Do Not Interfere with Siderophore Biosynthesis. Hegde, P., M.O. Orimoloye, S. Sharma, C.A. Engelhart, D. Schnappinger, and C.C. Aldrich. Tuberculosis, 2023. 140: 102346. PMID[37119793]. PMCID[PMC10247463].
[PubMed]. TB_05_2023.

12. Green Synthesis, Antimycobacterial Evaluation and Molecular Docking Studies of Novel 2,3-Dihydro-1H-pyrazol-4-ylnaphthalene-1,4-diones. Hiwarale, D.P., W.B. Chandane, S.M. Deshmukh, S.M. Arde, V.D. Sonawane, M.G. Kukade, N.M. Naik, K.D. Sonawane, G.S. Rashinkar, and S.G. Sonkamble. Journal of Molecular Structure, 2023. 1286: 135556. ISI[000990457800001].
[WOS]. TB_05_2023.

13. Isoflavonoid and Furanochromone Natural Products as Potential DNA Gyrase Inhibitors: Computational, Spectral, and Antimycobacterial Studies. Jagatap, V.R., I. Ahmad, D. Sriram, J. Kumari, D.K. Adu, B.W. Ike, M. Ghai, S.A. Ansari, I.A. Ansari, P.O.M. Wetchoua, R. Karpoormath, and H. Patel. ACS Omega, 2023. 8(18): p. 16228-16240. PMID[37179626]. PMCID[PMC10173323].
[PubMed]. TB_05_2023.

14. Therapeutic Potential of Coumestan Pks13 Inhibitors for Tuberculosis. Lun, S., S. Xiao, W. Zhang, S. Wang, H. Gunosewoyo, L.F. Yu, and W.R. Bishai. Antimicrobial Agents and Chemotherapy, 2023. 95(5): e02190-20. PMID[33558290]. PMCID[PMC8092898].
[PubMed]. TB_05_2023.

15. A New Complex of Silver(I) with Probenecid: Synthesis, Characterization, and Studies of Antibacterial and Extended Spectrum Β-Lactamases (ESBL) Inhibition Activities. Lustri, W.R., S.C. Lazarini, N.A. Simei Aquaroni, F.A. Resende, N.A. Aleixo, D.H. Pereira, B.C. Lustri, C.G. Moreira, C.M. Ribeiro, F.R. Pavan, D.H. Nakahata, A.M. Gonçalves, N.M. Nascimento-Júnior, and P.P. Corbi. Journal of Inorganic Biochemistry, 2023. 243: 112201. PMID[37003189].
[PubMed]. TB_05_2023.

16. Flavonoids of Chromolaena odorata (L.) R.M.King & H.Rob. as Potential Leads for Treatment against Tuberculosis. Omokhua-Uyi, A.G., B. Madikizela, A.O. Aro, M.A. Abdalla, J. Van Staden, and L.J. McGaw. South African Journal of Botany, 2023. 158: p. 158-165. PMID[37206481]. PMCID[PMC10182713].
[PubMed]. TB_05_2023.

17. Developing Synergistic Drug Combinations to Restore Antibiotic Sensitivity in Drug-resistant Mycobacterium tuberculosis. Omollo, C., V. Singh, E. Kigondu, A. Wasuna, P. Agarwal, A. Moosa, T.R. Ioerger, V. Mizrahi, K. Chibale, and D.F. Warner. Antimicrobial Agents and Chemotherapy, 2023. 65(5): e02554-20. PMID[33619062]. PMCID[PMC8092878].
[PubMed]. TB_05_2023.

18. Isonicotinic acid N-Oxide, from Isoniazid Biotransformation by Aspergillus niger, as an InhA Inhibitor Antituberculous Agent against Multiple and Extensively Resistant Strains Supported by in Silico Docking and ADME Prediction. Ragab, A.E., E.T. Badawy, S.M. Aboukhatwa, M.M. Abdel-Aziz, A. Kabbash, and K.A. Abo Elseoud. Natural Product Research, 2023. 37(10): p. 1687-1692. PMID[35876096].
[PubMed]. TB_05_2023.

19. Concise Route to Stereoselective Chlorobenzene-based Spiropyrrolidine Oxindoles for Pursuit as Antitubercular Agents. Rao, M.P., A. Chauhan, L. Pintilie, S.K. Singh, and M. Ganesh. Journal of Chemical Sciences, 2023. 135(2). ISI[000959622300003].
[WOS]. TB_05_2023.

20. Design, Synthesis, Molecular Docking, and Biological Evaluation of Coumarin-thymidine Analogs as Potent anti-TB Agents. Reddy, D.S., A. Sinha, M.M. Kurjogi, H. Shanavaz, and A. Kumar. Archiv der Pharmazie, 2023. 356(5): e2200633. PMID[36634969].
[PubMed]. TB_05_2023.

21. Acyldepsipeptide Antibiotics and a Bioactive Fragment Thereof Differentially Perturb Mycobacterium tuberculosis ClpSP1P2 Activity in Vitro. Schmitz, K.R., E.L. Handy, C.L. Compton, S. Gupta, W.R. Bishai, R.T. Sauer, and J.K. Sello. ACS Chemical Biology, 2023. 18(4): p. 724-733. PMID[32083462]. PMCID[PMC7842861].
[PubMed]. TB_05_2023.

22. Drug Susceptibility Distributions of Mycobacterium chimaera and Other Non-tuberculous Mycobacteria. Schulthess, B., D. Schäfle, N. Kälin, T. Widmer, and P. Sander. Antimicrobial Agents and Chemotherapy, 2023. 65(5): e02131-20. PMID[33619057]. PMCID[PMC8092894].
[PubMed]. TB_05_2023.

23. Glycerol Based Carbon Sulfonic acid Catalyzed Synthesis, in Silico Studies and in Vitro Biological Evaluation of Isonicotinohydrazide Derivatives as Potent Antimicrobial and Anti-tubercular Agents. Sethiya, A., D. Joshi, A. Manhas, N. Sahiba, D.K. Agarwal, P.C. Jha, and S. Agarwal. Heliyon, 2023. 9(2): e13226. PMID[36785822]. PMCID[PMC9918772].
[PubMed]. TB_05_2023.

24. The Antidepressant Sertraline Provides a Novel Host Directed Therapy Module for Augmenting TB Therapy. Shankaran, D., A. Singh, S. Dawa, P. Arumugam, S. Gandotra, and V. Rao. Elife, 2023. 12: e64834. PMID[36629405]. PMCID[PMC10159622].
[PubMed]. TB_05_2023.

25. Design, Synthesis and in Vitro Antitubercular Evaluation of Novel 7-Methoxy pyrrolo[1,2-a]quinoline Analogues as CYP 121 Inhibitors. Shivaprasad, K., S. Kidwai, S. Gopavaram, S.M. Saini, K. Reddy, S. Chugh, R. Singh, and S. Chandrashekharappa. Journal of Molecular Structure, 2023. 1284: 135439. ISI[000967592000001].
[WOS]. TB_05_2023.

26. New Palladium(II) Complexes Containing Methyl gallate and Octyl gallate: Effect against Mycobacterium tuberculosis and Campylobacter jejuni. Silva, R.T.C., M. Guidotti-Takeuchi, J.L.M. Peixoto, F.M. Demarqui, A.P. Mori, C.F. Dumont, G.R.A. Ferreira, G.M. Pereira, D.A. Rossi, P.P. Corbi, F.R. Pavan, C.O. Rezende Júnior, R.T. Melo, and W. Guerra. Molecules, 2023. 28(9): 3887. PMID[37175297]. PMCID[PMC10179749].
[PubMed]. TB_05_2023.

27. Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine nucleoside phosphorylase Inhibitors. Skácel, J., S. Djukic, O. Baszczyňski, F. Kalčic, T. Bílek, K. Chalupský, J. Kozák, A. Dvořáková, E. Tloušt'ová, Z. Král'ová, M. Šmídková, J. Voldřich, M. Rumlová, P. Pachl, J. Brynda, T. Vučková, M. Fábry, J. Snášel, I. Pichová, P. Řezáčová, H. Mertlíková-Kaiserová, and Z. Janeba. Journal of Medicinal Chemistry, 2023. 66(10): p. 6652-6681. PMID[37134237]. PMCID[PMC10226123].
[PubMed]. TB_05_2023.

28. N-Acylated Ciprofloxacin Derivatives: Synthesis and in Vitro Biological Evaluation as Antibacterial and Anticancer Agents. Struga, M., P. Roszkowski, A. Bielenica, D. Otto-Ślusarczyk, K. Stępień, J. Stefańska, A. Zabost, E. Augustynowicz-Kopeć, M. Koliński, S. Kmiecik, A. Myslovska, and M. Wrzosek. ACS Omega, 2023. 8(21): p. 18663-18684. PMID[37273589]. PMCID[PMC10233829].
[WOS]. TB_05_2023.

29. In Vitro and in Silico Studies of Glycyrrhetinic acid Derivatives as Anti-tubercular Agents. Vishwakarma, S., N.K. Khare, A. Shukla, F. Khan, P. Trivedi, V. Chaturvedi, and S.K. Srivastava. Letters in Drug Design & Discovery, 2023. 20(4): p. 479-487. ISI[000968078300009].
[WOS]. TB_05_2023.

30. Structure-directed Identification of Pyridine-2-methylamine Derivatives as MmpL3 Inhibitors for Use as Antitubercular Agents. Wen, Y., S.C. Lun, Y.X. Jiao, W. Zhang, T. Liu, F. Yang, J. Tang, W.R. Bishai, and L.F. Yu. European Journal of Medicinal Chemistry, 2023. 255: 115351. PMID[37116266]. PMCID[PMC10239758].
[PubMed]. TB_05_2023.

Patent Citations

31. Bacterial DNA Gyrase Inhibitors and Methods of Use Thereof for Treating Bacterial Infections. Leng, F., E. Alfonso, and Z. Deng. Patent. 2023. US2022-944006 20230136466: 94pp.
[Patent]. TB_05_2023.